Patrick McCall - 29 Jul 2021 Form 3 Insider Report for IN8BIO, INC. (INAB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
29 Jul 2021, 21:42:00 UTC
Next SEC filing
17 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason Minio, Attorney-in-Fact

Key filing fact

Patrick McCall filed Form 3 for IN8BIO, INC. (INAB) on 29 Jul 2021.

Key facts

  • This page summarizes Patrick McCall's Form 3 filing for IN8BIO, INC. (INAB).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 29 Jul 2021, 21:42.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INAB holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
188,816
Exercise price
$5.36
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Twenty-five percent (25%) of the shares subject to the option shall vest on February 1, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .